HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia

Nephrology Dialysis Transplantation

Volumn 28, Issue 12, 2013, Pages 3119-3126

  Masutani, Kosuke ^a,b   Ninomiya, Toshiharu ^b   Randhawa, Parmjeet ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Genotype; HLA mismatch; Polymerase chain reaction (PCR); Screening; Viremia

Indexed keywords

HLA A2 ANTIGEN; HLA B44 ANTIGEN; HLA DR15 ANTIGEN;

ADULT; ARTICLE; BK VIRUS INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DONOR SELECTION; FEMALE; GRAFT REJECTION; HLA MATCHING; HUMAN; HUMAN TISSUE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE;

GENOTYPE; HLA MISMATCH; POLYMERASE CHAIN REACTION (PCR); SCREENING; VIREMIA;

ADULT; ALLOGRAFTS; BK VIRUS; DNA, VIRAL; FEMALE; GRAFT REJECTION; HLA-A2 ANTIGEN; HLA-B44 ANTIGEN; HLA-DR SEROLOGICAL SUBTYPES; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; VIREMIA;

EID: 84890085233     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft298     Document Type: Article

References (27)

1. Brennan DC, Agha I, Bohl DL et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582-594
2. Hariharan S. BK virus nephritis after renal transplantation. Kidney Int 2006; 69: 655-662
3. Ramos E, Hirsch HH. Polyomavirus-associated nephropathy: updates on a persisting challenge. Transpl Infect Dis 2006; 8: 59-61
4. Hirsch HH, Randhawa P, AST Infectious Disease Community of Practice. BK virus in solid organ transplant recipients. Am J Transplant 2009; 9: S136-S146
5. Binet I, Nickeleit V, Hirsh HH et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918-922
6. Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103-109
7. Wadei HM, Rule AD, Lewin M et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant 2006; 6: 1025-1032
8. Trydzenskaya H, Sattler A, Müller K et al. Novel approach for improved assessment of phenotypic and functional characteristics of BKV-specific T-cell immunity. Transplantation 2011; 92: 1269-1277
9. Hammer MH, Brestrich G, Andree H et al. HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity. Am J Transplant 2006; 6: 625-631
10. Zimmerer JM, Horne PH, Fiessinger LA et al. Cytotoxic Effector Function of CD4-Independent, CD8+ T Cells Is Mediated by TNF-α/TNFR. Transplantation 2012; 94: 1103-1110
11. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723
12. Awadalla Y, Randhawa P, Ruppert K et al. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant 2005; 4: 1691-1696
13. Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renaltransplant recipients. N Engl J Med 2002; 347: 488-496
14. Bohl DL, Storch GA, Ryschkewitsch C et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 2213-2221
15. Ramos E, Drachenberg CB, Papadimitriou JC et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145-2151
16. Vasudev B, Hariharan S, Hussain SA et al. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68: 1834-1839
17. Drachenberg CB, Papadimitriou JC, Mann D et al. Negative impact of human leukocyte antigen matching in the outcome of polyomavirus nephropathy. Transplantation 2005; 80: 276-278
18. Comoli P, Basso S, Azzi A et al. Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. J Am Soc Nephrol 2003; 14: 3197-3204
19. Noss G. Human polyoma virus type BK infection and T antibody response in renal transplant recipients. Zentralbl Bakteriol Mikrobiol Hyg [A] 1987; 266: 567-574
20. Awadallah Y, Duquesnoy R, Randhawa P et al. HLA susceptibility to BKV infection. Am J Transplant 2006; 6: 640
21. Li J, Melenhorst J, Hensel N et al. T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus. J Gen Virol 2006; 87: 2951-2960
22. Ramaswami B, Popescu I, Macedo C et al. HLA-A01-,-A03-, and-A024-binding nanomeric epitopes in polyomavirus BK large T antigen. Hum Immunol 2009; 70: 722-728
23. Ramaswami B, Popescu I, Macedo C et al. The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response. Clin Vaccine Immunol 2011; 18: 815-824
24. Chen Y, Trofe J, Gordon J et al. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 2006; 80: 3495-3505
25. Yu N, Ohashi M, Alosco S et al. Accurate typing of HLA-A antigens and analysis of serological deficiencies. Tissue Antigens 1997; 50: 380-386
26. Bozón MV, Delgado JC, Selvakumar A et al. Error rate for HLAB antigen assignment by serology: implications for proficiency testing and utilization of DNA-based typing methods. Tissue Antigens 1997; 50: 387-394
27. Mytilineos J, Christ U, Lempert M et al. Comparison of typing results by serology and polymerase chain reaction with sequencespecific primers for HLA-Cw in 650 individuals. Tissue Antigens 1997; 50: 395-400